| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating | 
|---|
																	TD Cowen analyst Ryan Langston maintains DaVita (NYSE:DVA) with a Hold and lowers the price target from $154 to $133.
																	Barclays analyst Andrew Mok maintains DaVita (NYSE:DVA) with a Equal-Weight and lowers the price target from $149 to $143.
																	DaVita (NYSE:DVA) narrows FY2025 Adj EPS guidance from $10.20-$11.30 to $10.35-$11.15 vs $10.86 analyst estimate..
																	DaVita (NYSE:DVA) reported quarterly earnings of $2.51 per share which missed the analyst consensus estimate of $3.22 by 22.1 p...
																	
																	Barclays analyst Andrew Mok maintains DaVita (NYSE:DVA) with a Equal-Weight and lowers the price target from $160 to $149.
																	B of A Securities analyst Kevin Fischbeck maintains DaVita (NYSE:DVA) with a Underperform and lowers the price target from $...
																	DaVita reported a ransomware attack affecting 2.7 million patients, posted Q2 earnings above estimates, and authorized a $2 bil...
																	- SEC Filing